| DESCRIPTION OF ENHANCEMENTS |
This patch adds a cross-reference to the PRIMARY INGREDIENT field (#2)
being properly set. This caused the APD cross-reference on the
INGREDIENT 1 field (#1) and the INGREDIENT 2 field (#2) in the DRUG
INTERACTION file (#56) to be improperly set. Certain interactions
were not being properly tracked.
This patch corrects that defect. It also includes a post-install
routine to reset existing cross-references.
2. In the data update patch PSN*4*53, the units for the VA Product
INTERFERON BETA-1B,RECOMBINANT 9.6 MILLION UNT/VIL INJ (entry number
in the DRUG INGREDIENTS file (#50.416). This patch also corrects the
11809 in the VA PRODUCT file (#50.68)) was changed. This should have
caused all entries in the DRUG file (#50) matched to that product to
be unmatched. That unmatching did not take place. This patch causes
that unmatching.
After the patch is installed, the routines PSNJP54 and PSNOP54 should
be run from programmer mode. These routines will generate list of
patients who received combinations of drugs which should have caused
an interaction warning but did not. These routines MUST be run
within 60 days of the install of this patch, Once the routines have
incorrectly set APS cross-reference in that file and the APD cross-
been run, they may be deleted.
reference in the DRUG INTERACTION file (#56).
This patch also corrects two problems.
1. Under certain circumstances, the APS cross-reference on the PRIMARY
INGREDIENT field (#2) in the DRUG INGREDIENTS file (#50.416) was not
|
